National Bank of Canada’s InspireMD NSPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-206
Closed -$468 3101
2025
Q2
$468 Hold
206
﹤0.01% 2772
2025
Q1
$552 Hold
206
﹤0.01% 2635
2024
Q4
$542 Hold
206
﹤0.01% 2709
2024
Q3
$552 Hold
206
﹤0.01% 2473
2024
Q2
$494 Hold
206
﹤0.01% 2566
2024
Q1
$453 Hold
206
﹤0.01% 2606
2023
Q4
$556 Hold
206
﹤0.01% 2585
2023
Q3
$673 Hold
206
﹤0.01% 2629
2023
Q2
$498 Hold
206
﹤0.01% 2614
2023
Q1
$229 Hold
206
﹤0.01% 2635
2022
Q4
$173 Hold
206
﹤0.01% 2704
2022
Q3
$0 Hold
206
﹤0.01% 2823
2022
Q2
$0 Hold
206
﹤0.01% 2922
2022
Q1
$1K Hold
206
﹤0.01% 2792
2021
Q4
$1K Buy
+206
New +$773 ﹤0.01% 2757

Other funds holding NSPR

National Bank of Canada's NSPR Position: Q3 2025 in Review

National Bank of Canada sold out of InspireMD (NSPR) in Q3 2025, closing a stake of 206 shares — an estimated $468 sold.

National Bank of Canada first reported a position in NSPR in Q4 2021 and held it in 15 quarters. The position peaked at $1K in Q1 2022. 41 funds tracked by Wall St. Rank hold NSPR as of Q3 2025.

  • National Bank of Canada reported no remaining InspireMD position as of Q3 2025 after selling out during the quarter.
  • National Bank of Canada sold 206 InspireMD shares in Q3 2025, an estimated $468.
  • National Bank of Canada first reported a position in InspireMD in Q4 2021 and held it in 15 quarters.
  • National Bank of Canada's InspireMD position peaked at $1K in Q1 2022.
  • 41 funds tracked by Wall St. Rank held InspireMD as of Q3 2025.

Based on National Bank of Canada's 13F filing for Q3 2025, filed 14 Nov 2025.